Related Experiment Video
Updated: Nov 5, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Innovation in breakthrough drugs and vaccines: Development risk, patient impact, and value
Andrew E Prigodich1, Shuntai Wang1, Patrick Verhoest1
1Worldwide Research, Development and Medical, Pfizer Inc, United States.
Abstract:
Innovation has a crucial role in developing breakthrough drugs and vaccines that can change patients' lives. To better understand this role, we evaluated recent outcomes for assets developed using different types of innovation. Although all approaches have delivered breakthroughs, assets that modulate established biological targets with innovative scientific or technological designs provide a unique combination of reduced development risk, high patient impact, and high commercial value. This type of asset currently represents a relatively small proportion of approved drugs and vaccines, but we anticipate that an increasing body of scientific knowledge and ongoing technological advancements could offer opportunities to grow this category in the future.
Related Concept Videos
Clinical Trials: Overview
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Drug Discovery: Overview
Microorganisms in Medicine and Therapeutics
Drug Products: Biologics, Biosimilars and Interchangeables
Preclinical Development: Overview

